Stockreport

Revolution Medicines to Participate in Upcoming Investor Conferences [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF targeted therapies for RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive officer and chairman, will be a featured [Read more]